Skip to content

IVM Survey Among Reproductive Medicine Specialists

Survey of Fertility Specialists' Knowledge of, Experience With, and Attitudes Toward the Use of in Vitro Maturation of Oocytes in Reproductive Medicine

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04488211
Enrollment
200
Registered
2020-07-27
Start date
2020-07-30
Completion date
2020-12-31
Last updated
2021-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IVM

Brief summary

Although IVM as a laboratory technology in reproductive medicine has existed for many decades, there is a lack of well-designed studies comparing the efficiency and the patient satisfaction related to IVM as compared to standard ovarian stimulation for IVF. In view of this, and in order to identify unmet needs of fertility specialists with regard to the application of IVM, the investigator developed the idea of a worldwide web-based survey analysis of fertility specialists' insights and experiences regarding IVM.

Detailed description

The IVM survey will be structured as a series of open questions and multiple-choice questions. In most of the questions, a single answer will be required by participants. A small number of questions will allow multiple answers. The survey will be web-based. Invitations to participate in the survey will be emailed on three occasions to selected fertility specialists worldwide who are affiliated to a public or private fertility clinic. Clinics will be identified based on whether they have worked with IVM previously but stopped, and clinics with appropriate size to offer IVM competence. When no response is obtained from selected fertility specialists, e-mails will be sent to affiliated colleagues working at the same fertility clinic. When analyzing the survey results, care will be taken to analyse the responses per fertility clinic, as responses from different fertility specialists working in the same fertility clinic should be avoided. Results will be analysed using a method that assigns equal weight per clinic and a method that weights clinic responses based on treatment volume (number of IVF cycles).

Interventions

OTHERSurvey

The IVM survey will be structured as a series of open questions and multiple-choice questions.

Sponsors

CooperSurgical Inc.
CollaboratorINDUSTRY
Universitair Ziekenhuis Brussel
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* IVF clinics that have worked with IVM previously but stopped * clinics with appropriate size to offer IVM

Design outcomes

Primary

MeasureTime frameDescription
Name of the measurement: Application of in vitro maturation (IVM) of oocytes as a laboratory tool1 monthMeasurement tool: questionnaire; unit of measure: % of respondents who use oocyte in vitro maturation in the laboratory;
Name of the measurement: Appreciation of IVM as a laboratory technique1 monthMeasurement tool: questionnaire; unit of measure: % of respondents who believe there is a role for IVM in the ART (assisted reproductive technology ) clinic

Secondary

MeasureTime frameDescription
Name of the measurement: Annual number of egg retrievals for IVM1 monthMeasurement tool: questionnaire; unit of measure: number

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026